At least 20,000 volunteers In Ecuador, they will participate in tests of three vaccines against Covid-19 starting in November, in a WHO project in which the Ministry of Health and the San Francisco de Quito University (USFQ) are involved.
The professor of that university, Enrique Terán, indicated that the volunteers who are part of the WHO clinical study, called Solidarity Vacunas, must undergo a prior health assessment to ensure that they are in the right conditions for the application of the doses.
The researcher noted that as this is an initial efficacy and safety study, the participation of people who have already been infected is not recommended previously from coronavirus.
“This analysis tries to focus on the group most affected, that is, young adults from 20 to 50 years“, he specified.
The USFQ in conjunction with the Public Health Portfolio will begin the recruitment stage starting next October in Quito and Guayaquil, cities with the highest rate of infections nationwide, with more than 23,000 and 13,000 positives, respectively.
After the final presentation of the protocol with the study guidelines, its approval remains in the hands of the National Agency for Regulation, Control and Sanitary Surveillance (ARCSA) and the ethics committees, before proceeding with its implementation.
Once the project starts, those who participate in the study on the experimental vaccines will be monitored by those in charge of the investigation.
At the express request of the WHO, it is not yet possible to know the three vaccines to be tested in Ecuador, since the International Organization negotiates its supply with direct manufacturers.
However, Terán indicated that the doses that will be tested in the country “are in their state of greatest development and they are in phase three of execution in some countries. “
Last March the WHO began this large clinical trial worldwide in order to find the most effective treatment for Covid-19.
Since last June the USFQ and the Government have been in contact with representatives of the World Health Organization In order for Ecuador to be part of the clinical trials that are currently being carried out worldwide.
Regarding the tests in the framework of the campaign Solidarity Vaccine, the Director General of WHO, Tedros AdhanomHe indicated that the project “is designed to generate the robust data that we need, to show which treatments are the most effective.”
The Ecuadorian Ministry of Health is expected to pronounce on the matter in the next days.
Ecuador registered 113,206 infections and 10,749 deaths from Covid-19 as of Thursday, of which 6,971 were confirmed and 3,778 are counted as probable deaths from the disease.